Drug
Who makes tacrolimus extended-release capsules?
2 companies list tacrolimus extended-release capsules as a human prescription drug, including under the names ASTAGRAF XL. Forms: capsule, coated, extended release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing tacrolimus extended-release capsules
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Astellas Pharma US, Inc.Japan | capsule, coated, extended release | NDANDA204096 | 3 | 8 |
| Chengdu Suncadia Medicine Co., Ltd.China | capsule, coated, extended release | ANDAANDA215012 | 3 | 1 |
Enquiry
Common questions
- Who makes tacrolimus extended-release capsules?
- 2 companies list tacrolimus extended-release capsules as a human prescription drug in the openFDA NDC Directory, led by Astellas Pharma US, Inc., Chengdu Suncadia Medicine Co., Ltd.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic ASTAGRAF XL?
- 1 company lists tacrolimus extended-release capsules under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.